spacer
spacer

PDBsum entry 2x8c

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Oxidoreductase/flavoprotein PDB id
2x8c

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
588 a.a. *
Ligands
FAD ×2
PGE ×3
PEG
* Residue conservation analysis
PDB id:
2x8c
Name: Oxidoreductase/flavoprotein
Title: Thioredoxin glutathione reductase from schistosoma mansoni with the reduced c-terminal end
Structure: Thioredoxin glutathione reductase. Chain: a, b. Engineered: yes
Source: Schistosoma mansoni. Blood fluke. Organism_taxid: 6183. Expressed in: escherichia coli. Expression_system_taxid: 469008.
Resolution:
3.10Å     R-factor:   0.220     R-free:   0.293
Authors: F.Angelucci,D.Dimastrogiovanni,G.Boumis,M.Brunori,A.E.Miele, F.Saccoccia,A.Bellelli
Key ref: F.Angelucci et al. (2010). Mapping the catalytic cycle of Schistosoma mansoni thioredoxin glutathione reductase by X-ray crystallography. J Biol Chem, 285, 32557-32567. PubMed id: 20659890 DOI: 10.1074/jbc.M110.141960
Date:
08-Mar-10     Release date:   21-Jul-10    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
Q962Y6  (Q962Y6_SCHMA) -  thioredoxin-disulfide reductase from Schistosoma mansoni
Seq:
Struc:
 
Seq:
Struc:
598 a.a.
588 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.1.8.1.9  - thioredoxin-disulfide reductase (NADPH).
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: [thioredoxin]-dithiol + NADP+ = [thioredoxin]-disulfide + NADPH + H+
[thioredoxin]-dithiol
+ NADP(+)
= [thioredoxin]-disulfide
+ NADPH
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
DOI no: 10.1074/jbc.M110.141960 J Biol Chem 285:32557-32567 (2010)
PubMed id: 20659890  
 
 
Mapping the catalytic cycle of Schistosoma mansoni thioredoxin glutathione reductase by X-ray crystallography.
F.Angelucci, D.Dimastrogiovanni, G.Boumis, M.Brunori, A.E.Miele, F.Saccoccia, A.Bellelli.
 
  ABSTRACT  
 
Schistosomiasis is the second most widespread human parasitic disease. It is principally treated with one drug, praziquantel, that is administered to 100 million people each year; less sensitive strains of schistosomes are emerging. One of the most appealing drug targets against schistosomiasis is thioredoxin glutathione reductase (TGR). This natural chimeric enzyme is a peculiar fusion of a glutaredoxin domain with a thioredoxin selenocysteine (U)-containing reductase domain. Selenocysteine is located on a flexible C-terminal arm that is usually disordered in the available structures of the protein and is essential for the full catalytic activity of TGR. In this study, we dissect the catalytic cycle of Schistosoma mansoni TGR by structural and functional analysis of the U597C mutant. The crystallographic data presented herein include the following: the oxidized form (at 1.9 Å resolution); the NADPH- and GSH-bound forms (2.3 and 1.9 Å, respectively); and a different crystal form of the (partially) reduced enzyme (3.1 Å), showing the physiological dimer and the entire C terminus of one subunit. Whenever possible, we determined the rate constants for the interconversion between the different oxidation states of TGR by kinetic methods. By combining the crystallographic analysis with computer modeling, we were able to throw further light on the mechanism of action of S. mansoni TGR. In particular, we hereby propose the putative functionally relevant conformational change of the C terminus after the transfer of reducing equivalents from NADPH to the redox sites of the enzyme.
 

 

spacer

spacer